Twenty million dollars. That's the fine California Attorney General Rob Bonta is threatening against nonprofit organizations whose crime, apparently, is offering pregnant women a hormone that might save their baby's life. The nonprofits in question — Heartbeat International and Real Options — provide access to progesterone, a naturally occurring hormone, to women who've taken the first abortion pill and changed their minds.
In California, that's not compassion. That's a violation of Unfair Competition and False Advertising laws.
Here's what Bonta's office is actually targeting. When a woman takes mifepristone — the first of two pills in a chemical abortion — she has a window before taking the second pill, misoprostol, where progesterone can potentially counteract the effects and allow the pregnancy to continue. According to the Daily Wire, almost 70% of cases where progesterone is administered result in the baby being saved. These nonprofits connect women who've changed their minds with medical providers who offer that option.
Terry Schilling, President of the American Principles Project, laid it out plainly: "Without evidence as to what these organizations are doing wrong, Bonta has threatened to fine these nonprofit organizations a debilitating $20 million for their work in promoting access to a hormone that does nothing but restore lost equilibrium to the body."
The scale of what's at stake matters here. In 2023, 63% of over 1 million U.S. abortions were chemically induced — meaning the mifepristone-misoprostol regimen. That percentage has only grown since the FDA expanded access to mail-order abortion pills under the Biden administration. Over 10% of chemical abortions lead to complications. These nonprofits exist, in part, because a meaningful number of women take that first pill and immediately regret it.
Bonta's office frames this as consumer protection — the claim being that progesterone reversal is unproven and that advertising it constitutes false advertising. The FDA has not approved progesterone specifically as an abortion-pill reversal treatment, and Planned Parenthood has lobbied aggressively against the protocol. That's the stated basis for a $20 million enforcement threat against organizations that are, by every observable measure, helping women who are asking for help.
But progesterone isn't experimental. It's been prescribed to pregnant women for decades to prevent miscarriage. The dispute isn't really about whether the hormone is safe — it's about whether women should be told they have a choice after starting a chemical abortion. Heartbeat International and Real Options say yes. Rob Bonta and Planned Parenthood say that information is too dangerous for women to have.
The practical math is straightforward. California's attorney general has the resources to threaten small nonprofits with eight-figure fines for offering a legal hormone to willing patients. The same state has spent years declining to prosecute property crimes, watching retail theft gut entire shopping districts, and struggling to explain why recidivism keeps climbing. Priorities aren't what a government says they are. Priorities are what a government spends its enforcement power on.
A $20 million fine for helping a woman who changed her mind. Progesterone — available at any pharmacy, prescribed by OB-GYNs nationwide, used safely for generations. The state isn't arguing the hormone is dangerous. It's arguing that offering it to the wrong patients, for the wrong reasons, is a crime worth $20 million.
When the penalty for saving a life dwarfs the penalty for stealing a television, the law has stopped being about protection.